The Use of Molecular Profile in Renal Cancer - Martin Voss

(Length of Discussion: 10 min)

Daniel George and Martin Voss discuss the evolving management of patients with advanced renal cell carcinoma with a focus on the genomic landscape in high risk localized disease. Based on molecular profiles, we may be able to prognosticate more accurately on their risk for recurrence. Applicability of this biomarker data will guide the future in appropriate therapeutic choices.


Martin H. Voss, MD, Medical Oncologist, Memorial Sloan Kettering Cancer Center

Daniel George, MD


Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.